JP2006512366A - ピラゾロ［３，４−ｄ］ピリミジン誘導体及び処置におけるその使用 - Google Patents

ピラゾロ［３，４−ｄ］ピリミジン誘導体及び処置におけるその使用 Download PDF

Info

Publication number
JP2006512366A
JP2006512366A JP2004562221A JP2004562221A JP2006512366A JP 2006512366 A JP2006512366 A JP 2006512366A JP 2004562221 A JP2004562221 A JP 2004562221A JP 2004562221 A JP2004562221 A JP 2004562221A JP 2006512366 A JP2006512366 A JP 2006512366A
Authority
JP
Japan
Prior art keywords
alkyl
het
methyl
optionally substituted
pyrazolo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2004562221A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006512366A5 (enExample
Inventor
バサラブ，グレゴリー
アイアーマン，ジョーゼフ
ゴウラヴァラム，マドフスダン
グリーン，オルインカ
マックファーソン，ローレンス
モーニングスター，マーシャル
ングエン，タン
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
AstraZeneca AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AstraZeneca AB filed Critical AstraZeneca AB
Publication of JP2006512366A publication Critical patent/JP2006512366A/ja
Publication of JP2006512366A5 publication Critical patent/JP2006512366A5/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
JP2004562221A 2002-12-20 2003-12-19 ピラゾロ［３，４−ｄ］ピリミジン誘導体及び処置におけるその使用 Pending JP2006512366A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0203825A SE0203825D0 (sv) 2002-12-20 2002-12-20 Novel fused heterocycles and uses thereof
PCT/SE2003/002033 WO2004056831A1 (en) 2002-12-20 2003-12-19 PYRAZOLO [3,4-d] PYRIMIDINE DERIVATIVES AND THEIR USE IN THE TREATMENT OF H.PYLORI INFECTION

Publications (2)

Publication Number Publication Date
JP2006512366A true JP2006512366A (ja) 2006-04-13
JP2006512366A5 JP2006512366A5 (enExample) 2006-09-28

Family

ID=20289974

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004562221A Pending JP2006512366A (ja) 2002-12-20 2003-12-19 ピラゾロ［３，４−ｄ］ピリミジン誘導体及び処置におけるその使用

Country Status (9)

Country Link
US (1) US20070004761A1 (enExample)
EP (1) EP1585748B1 (enExample)
JP (1) JP2006512366A (enExample)
AT (1) ATE349448T1 (enExample)
AU (1) AU2003288869A1 (enExample)
DE (1) DE60310767T2 (enExample)
ES (1) ES2278211T3 (enExample)
SE (1) SE0203825D0 (enExample)
WO (1) WO2004056831A1 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2012510996A (ja) * 2008-12-06 2012-05-17 イントラ−セルラー・セラピーズ・インコーポレイテッド 有機化合物

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030211040A1 (en) 2001-08-31 2003-11-13 Paul Greengard Phosphodiesterase activity and regulation of phosphodiesterase 1B-mediated signaling in brain
WO2007143705A2 (en) 2006-06-06 2007-12-13 Intra-Cellular Therapies, Inc. Organic compounds
EP2081431B1 (en) 2006-11-13 2013-01-16 Intra-Cellular Therapies, Inc. Organic compounds
JP5701608B2 (ja) 2007-12-06 2015-04-15 イントラ−セルラー・セラピーズ・インコーポレイテッドＩｎｔｒａ−Ｃｅｌｌｕｌａｒ Ｔｈｅｒａｐｉｅｓ， Ｉｎｃ． 有機化合物
WO2009134666A1 (en) 2008-04-29 2009-11-05 Boehringer Ingelheim International Gmbh Indazole compounds as ccr1 receptor antagonists
US8293917B2 (en) * 2008-05-06 2012-10-23 Boehringer Ingelheim International Gmbh Pyrazole compounds as CCR1 antagonists
BRPI0919844A2 (pt) 2008-09-26 2019-09-24 Boehringer Ingelheim Int compostos de azaindazol como antagonistas do receptor ccr1
BRPI0922809A2 (pt) 2008-12-06 2018-05-29 Intracellular Therapies Inc compostos orgânicos
EP2367430B1 (en) 2008-12-06 2014-08-13 Intra-Cellular Therapies, Inc. Organic compounds
SG10201507362TA (en) 2009-08-05 2015-10-29 Intra Cellular Therapies Inc Novel Regulatory Proteins And Inhibitors
PE20121433A1 (es) 2009-10-21 2012-11-10 Boehringer Ingelheim Int Compuestos de indazol y pirazolopiridina como antagonistas del receptor de ccr1
US8927550B2 (en) 2009-10-27 2015-01-06 Boehringer Ingelheim International Gmbh Heterocyclic compounds as CCR1 receptor antagonists
MX2012006524A (es) * 2009-12-08 2012-07-17 Boehringer Ingelheim Int Proceso para la sintesis de compuestos intermedios de utilidad para preparar compuestos sustituidos de indazol y azaindol.
WO2011137109A1 (en) 2010-04-30 2011-11-03 Boehringer Ingelheim International Gmbh Azaindazole amide compounds as ccr1 receptor antagonists
US9434730B2 (en) 2010-05-31 2016-09-06 Intra-Cellular Therapies, Inc. PDE1 inhibitor compounds
EP2590657A4 (en) 2010-05-31 2014-02-12 Intra Cellular Therapies Inc ORGANIC CONNECTIONS
WO2012087782A1 (en) 2010-12-23 2012-06-28 Boehringer Ingelheim International Gmbh Pyrazolopiperidine compounds as ccr1 receptor antagonists
US9546175B2 (en) 2014-08-07 2017-01-17 Intra-Cellular Therapies, Inc. Organic compounds
CN118834214A (zh) 2018-06-04 2024-10-25 爱克思科技有限公司 作为腺苷受体拮抗剂的吡唑并嘧啶化合物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3839839A1 (de) * 1988-11-25 1990-05-31 Henning Berlin Gmbh Mittel zur behandlung von chronisch entzuendlichen darmerkrankungen
SE0102315D0 (sv) * 2001-06-28 2001-06-28 Astrazeneca Ab Compounds

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
JPN6010004125, Ｊｏｕｒｎａｌ ｏｆ ｔｈｅ Ｃｈｅｍｉｃａｌ Ｓｏｃｉｅｔｙ，Ｐｅｒｋｉｎ Ｔｒａｎｓａｃｔｉｏｎｓ １，（１９７７），（７），ｐ．７６５−７ *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2012510996A (ja) * 2008-12-06 2012-05-17 イントラ−セルラー・セラピーズ・インコーポレイテッド 有機化合物

Also Published As

Publication number Publication date
EP1585748A1 (en) 2005-10-19
ES2278211T3 (es) 2007-08-01
SE0203825D0 (sv) 2002-12-20
AU2003288869A1 (en) 2004-07-14
DE60310767T2 (de) 2007-10-11
US20070004761A1 (en) 2007-01-04
DE60310767D1 (de) 2007-02-08
WO2004056831A1 (en) 2004-07-08
ATE349448T1 (de) 2007-01-15
EP1585748B1 (en) 2006-12-27

Similar Documents

Publication Publication Date Title
US7371757B2 (en) Fused heterocycles as inhibitors of glutamate racemase(MURI)
CN113527293B (zh) Kras g12c突变蛋白抑制剂及其药物组合物、制备方法和用途
JP2006512366A (ja) ピラゾロ［３，４−ｄ］ピリミジン誘導体及び処置におけるその使用
ES2706745T3 (es) Compuestos de aminopiridazinona como inhibidores de proteína cinasa
ES2770693T3 (es) Derivados de imidazopiridazina como inhibidores de caseína quinasa 1 delta/épsilon
PT1689751E (pt) Novas 5,7-diaminopirazolo[4,3-d]pirimidinas com actividade inibidora de pde-5
HUE025223T2 (en) Quinoline and quinoxaline derivatives as kinase inhibitors
WO2005049033A1 (en) Pyrazole derivatives as inhibitors of receptor tyrosyne kinases
HK1054034A1 (en) Substituted pyrrolopyridinone derivatives useful as phosphodiesterase inhibitors
EP3710431A1 (en) Substituted pyrrolopyrimidine jak inhibitors and methods of making and using the same
PT819129E (pt) Derivados pirazole e processos para a sua preparacao
WO2016192132A1 (zh) 作为alk抑制剂的嘧啶衍生物
CN112292374B (zh) 一种新型磷酸肌醇3-激酶抑制剂及其制备方法和用途
ES2324837T3 (es) Derivados de piridina utiles como inhibidores de la pkc-theta.
EP3625234B1 (en) Hexahydropyrazolo [1,2-a] diazepinones and related heterocycles as inhibitors of rip-1 kinase
KR20240168922A (ko) 방향족 헤테로사이클릭 화합물, 그의 제조 방법 및 그의 용도
WO2018133875A1 (zh) Jak酶抑制剂及其制备方法和用途
CN116891437B (zh) 氨基酸衍生物、药物组合物及其制备方法和应用
US20070275954A1 (en) Novel Fused Heterocycles and Uses Thereof
ES2223008T3 (es) Compuestos utiles como ingrediente activo de un medicamento para el tratamiento preventivo y/o terapeutico de enfermedades neurodegenerativas.
JP2011529085A (ja) 抗ウイルス化合物
JP2010540422A (ja) チエノピリミジン化合物類
CN115894376B (zh) 一种芳香族酰胺类化合物、药物组合物及其用途
HK40112157A (zh) Enpp1抑制剂的药物用途
MXPA06005597A (en) Pyrazole derivatives as inhibitors of receptor tyrosyne kinases

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20060808

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20060808

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20100128

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20100427

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20100510

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20100528

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20100604

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20100628

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20100705

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20101018